For: | Lupberger J, Hildt E. Hepatitis B virus-induced oncogenesis. World J Gastroenterol 2007; 13(1): 74-81 [PMID: 17206756 DOI: 10.3748/wjg.v13.i1.74] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i1/74.htm |
Number | Citing Articles |
1 |
Choongho Lee, Rômulo Novaes. Therapeutic Modulation of Virus‐Induced Oxidative Stress via the Nrf2‐Dependent Antioxidative Pathway. Oxidative Medicine and Cellular Longevity 2018; 2018(1) doi: 10.1155/2018/6208067
|
2 |
Ashutosh Tiwari, Navin Khanna, Subrat K. Acharya, Subrata Sinha. Humanization of high affinity anti-HBs antibody by using human consensus sequence and modification of selected minimal positional template and packing residues. Vaccine 2009; 27(17): 2356 doi: 10.1016/j.vaccine.2009.02.019
|
3 |
Kristof Vrancken, Jan Paeshuyse, Sandra Liekens. Angiogenic Activity of Hepatitis B and C Viruses. Antiviral Chemistry and Chemotherapy 2012; 22(4): 159 doi: 10.3851/IMP1987
|
4 |
X Qiu, S Dong, F Qiao, S Lu, Y Song, Y Lao, Y Li, T Zeng, J Hu, L Zhang, L Zhang, H Fan. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma. Oncogene 2013; 32(27): 3296 doi: 10.1038/onc.2013.150
|
5 |
Cesar Lopez-Camarillo, Laurence A. Marchat, Elena Arechaga-Ocampo, Carlos Perez-Plasencia, Oscar del Moral-Hernandez, Elizabeth J. Castaneda-Ortiz, Sergio Rodriguez-Cuevas. MetastamiRs: Non-Coding MicroRNAs Driving Cancer Invasion and Metastasis. International Journal of Molecular Sciences 2012; 13(2): 1347 doi: 10.3390/ijms13021347
|
6 |
Pinar Ozkal-Baydin. How did hepatitis B virus effect the host genome in the last decade?. World Journal of Hepatology 2014; 6(12): 851-859 doi: 10.4254/wjh.v6.i12.851
|
7 |
HAO XU, GUANGMING LI, ZHANYI YUE, CHENGZHONG LI. HCV core protein-induced upregulation of microRNA-196a promotes aberrant proliferation in hepatocellular carcinoma by targeting FOXO1. Molecular Medicine Reports 2016; 13(6): 5223 doi: 10.3892/mmr.2016.5159
|
8 |
Xing Guo Wang, Ekaterina Revskaya, Ruth A. Bryan, Howard D. Strickler, Robert D. Burk, Arturo Casadevall, Ekaterina Dadachova, Mikhail Blagosklonny. Treating Cancer as an Infectious Disease—Viral Antigens as Novel Targets for Treatment and Potential Prevention of Tumors of Viral Etiology. PLoS ONE 2007; 2(10): e1114 doi: 10.1371/journal.pone.0001114
|
9 |
S. Ognjanovic, J.-M. Yuan, A. K. Chaptman, Y. Fan, M. C. Yu. Genetic polymorphisms in the cytokine genes and risk of hepatocellular carcinoma in low-risk non-Asians of USA. Carcinogenesis 2009; 30(5): 758 doi: 10.1093/carcin/bgn286
|
10 |
Haresh Mani, David E. Kleiner. Liver biopsy findings in chronic hepatitis B #. Hepatology 2009; 49(Suppl. 5): S61 doi: 10.1002/hep.22930
|
11 |
|
12 |
Nimrah Akram, Muhammad Imran, Mamoona Noreen, Fayyaz Ahmed, Muhammad Atif, Zareen Fatima, Ahmed Bilal Waqar. Oncogenic Role of Tumor Viruses in Humans. Viral Immunology 2017; 30(1): 20 doi: 10.1089/vim.2016.0109
|
13 |
Ali Ramezani, Mehdi Parsa Nahad, Ebrahim Faghihloo. The role of Nrf2 transcription factor in viral infection. Journal of Cellular Biochemistry 2018; 119(8): 6366 doi: 10.1002/jcb.26897
|
14 |
Xue‑Li Jin, Suk Hong, Hwajung Kim, Sun‑Kyung Lee, Nam‑Joon Yi, Kwang‑Woong Lee, Kyung‑Suk Suh. Antiviral therapy may decrease HBx, affecting cccDNA and MSL2 in hepatocarcinogenesis. Oncology Letters 2019; doi: 10.3892/ol.2019.10833
|
15 |
Gang Huang, Yuan Yang, Feng Shen, Ze-ya Pan, Si-yuan Fu, Wan Yee Lau, Wei-ping Zhou, Meng-chao Wu. Early Viral Suppression Predicts Good Postoperative Survivals in Patients with Hepatocellular Carcinoma with a High Baseline HBV-DNA Load. Annals of Surgical Oncology 2013; 20(5): 1482 doi: 10.1245/s10434-012-2803-7
|
16 |
Amy C. McClune, Myron J. Tong. Chronic Hepatitis B and Hepatocellular Carcinoma. Clinics in Liver Disease 2010; 14(3): 461 doi: 10.1016/j.cld.2010.05.009
|
17 |
Lung-Yi Mak, Matthew Shing Hin Chung, Xue Li, Francisco Tsz Tsun Lai, Eric Yuk Fai Wan, Celine Sze Ling Chui, Franco Wing Tak Cheng, Esther Wai Yin Chan, Ching Lung Cheung, Ivan Chi Ho Au, Xi Xiong, Wai-Kay Seto, Man-Fung Yuen, Carlos King Ho Wong, Ian Chi Kei Wong. Effects of SARS-CoV-2 infection on incidence and treatment strategies of hepatocellular carcinoma in people with chronic liver disease. World Journal of Hepatology 2024; 16(2): 211-228 doi: 10.4254/wjh.v16.i2.211
Abstract(327) |
Core Tip(360) |
Full Article(HTML)(1708)
|
Full Article with Cover (PDF)-6787K(71)
|
Full Article (Word)-1662K(11)
|
Audio-745K(0)
|
Peer-Review Report-180K(38)
|
Answering Reviewers-424K(43)
|
Supplementary Material-127K(45)
|
Full Article (PDF)-6277K(73)
|
Full Article (XML)-185K(38)
|
Times Cited (0)
|
Total Visits (4503)
|
Open
|
18 |
XUDONG LIU, YANYUN TU, XIN DENG, JIAN LIANG. The S protein of hepatitis B virus promotes collagen type I expression in hepatic stellate cells by virtue of hepatocytes. Biomedical Reports 2014; 2(1): 97 doi: 10.3892/br.2013.201
|
19 |
Natalia Freitas, Tetyana Lukash, Sumedha Gunewardena, Benjamin Chappell, Betty L. Slagle, Severin O. Gudima, Rozanne M. Sandri-Goldin. Relative Abundance of Integrant-Derived Viral RNAs in Infected Tissues Harvested from Chronic Hepatitis B Virus Carriers. Journal of Virology 2018; 92(10) doi: 10.1128/JVI.02221-17
|
20 |
T. Pollicino, C. Saitta, G. Raimondo. Hepatocellular carcinoma: the point of view of the hepatitis B virus. Carcinogenesis 2011; 32(8): 1122 doi: 10.1093/carcin/bgr108
|
21 |
Hossein Ghaderi-Zefrehi, Maryam Rezaei, Farzin Sadeghi, Mohammad Heiat. Genetic polymorphisms in DNA repair genes and hepatocellular carcinoma risk. DNA Repair 2021; 107: 103196 doi: 10.1016/j.dnarep.2021.103196
|
22 |
Carlos Eduardo Becker, Angelo Alves de Mattos, Maurício Reis Bogo, Fernanda Branco, Roberta Sitnik, Nelson Alexandre Kretzmann. Genotyping of hepatitis B virus in a cohort of patients evaluated in a hospital of Porto Alegre, south of Brazil. Arquivos de Gastroenterologia 2010; 47(1): 13 doi: 10.1590/S0004-28032010000100003
|
23 |
|
24 |
Wei Luo, Junxia Wang, Dengfeng Xu, Huili Bai, Yangli Zhang, Yuhong Zhang, Xiaosong Li. Engineered zinc-finger transcription factors inhibit the replication and transcription of HBV in�vitro and in�vivo. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3396
|
25 |
Yun Hong, Lin Zhou, Haiyang Xie, Weilin Wang, Shusen Zheng. Differences in antiproliferative effect of STAT3 inhibition in HCC cells with versus without HBV expression. Biochemical and Biophysical Research Communications 2015; 461(3): 513 doi: 10.1016/j.bbrc.2015.04.058
|
26 |
Amy P. Chiu, Barbara R. Tschida, Tung-Ting Sham, Lilian H. Lo, Branden S. Moriarity, Xiao-Xiao Li, Regina C. Lo, David E. Hinton, Dewi K. Rowlands, Chi-On Chan, Daniel K.W. Mok, David A. Largaespada, Nadia Warner, Vincent W. Keng. HBx-K130M/V131I Promotes Liver Cancer in Transgenic Mice via AKT/FOXO1 Signaling Pathway and Arachidonic Acid Metabolism. Molecular Cancer Research 2019; 17(7): 1582 doi: 10.1158/1541-7786.MCR-18-1127
|
27 |
Wenpeng Li, Nadia Warner, Vitina Sozzi, Lilly Yuen, Danni Colledge, Tong Li, Hui Zhuang, Stephen Locarnini, Peter A. Revill. Hepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype. Hepatology International 2013; 7(2): 443 doi: 10.1007/s12072-012-9411-2
|
28 |
Philippe Noriel Q. Pascua, Jun-Han Lee, Min-Suk Song, Soo-Jin Park, Yun Hee Baek, Byung-Hoon Ann, Eun-Young Shin, Eung-Gook Kim, Young-Ki Choi. Role of the p21-activated kinases (PAKs) in influenza A virus replication. Biochemical and Biophysical Research Communications 2011; 414(3): 569 doi: 10.1016/j.bbrc.2011.09.119
|
29 |
Natalia Freitas, Jessica Salisse, Celso Cunha, Ilia Toshkov, Stephan Menne, Severin O. Gudima. Hepatitis delta virus infects the cells of hepadnavirus-induced hepatocellular carcinoma in woodchucks. Hepatology 2012; 56(1): 76 doi: 10.1002/hep.25663
|
30 |
Jie Dai, En-Qiang Chen, Lang Bai, Dao-Yin Gong, Qiao-Ling Zhou, Xing Cheng, Fei-Jun Huang, Hong Tang. Biological characteristics of the rtA181T/sW172* mutant strain of Hepatitis B virus in animal model. Virology Journal 2012; 9(1) doi: 10.1186/1743-422X-9-280
|
31 |
Jing Zhao, Chenji Wang, Jia Wang, Xianmei Yang, Ni Diao, Qiang Li, Wenzhang Wang, Lingling Xian, Zhou Fang, Long Yu. E3 ubiquitin ligase Siah-1 facilitates poly-ubiquitylation and proteasomal degradation of the hepatitis B viral X protein. FEBS Letters 2011; 585(19): 2943 doi: 10.1016/j.febslet.2011.08.015
|
32 |
Gyula Végső, Jenő Járay. Malignant tumors following renal transplantation. Orvosi Hetilap 2007; 148(45): 2115 doi: 10.1556/oh.2007.28238
|
33 |
Shuyu Li, Mao Mao. Next generation sequencing reveals genetic landscape of hepatocellular carcinomas. Cancer Letters 2013; 340(2): 247 doi: 10.1016/j.canlet.2012.09.027
|
34 |
V. E. Gurtsevitch. Human oncogenic viruses: Hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis. Biochemistry (Moscow) 2008; 73(5): 504 doi: 10.1134/S0006297908050039
|
35 |
Gang Huang, Peng-peng Li, Wan Yee Lau, Ze-ya Pan, Ling-hao Zhao, Zhen-guang Wang, Meng-chao Wang, Wei-ping Zhou. Antiviral Therapy Reduces Hepatocellular Carcinoma Recurrence in Patients With Low HBV-DNA Levels. Annals of Surgery 2018; 268(6): 943 doi: 10.1097/SLA.0000000000002727
|
36 |
Arzu ŞAHİN, Filiz BAYAR. Evaluation of Platelet Indexes of HBsAg Positive Patients. Ege Tıp Bilimleri Dergisi 2022; 5(3): 92 doi: 10.33713/egetbd.1202058
|
37 |
Shaian Tavakolian, Seidamir Pasha Tabaeian, Abolfazl Namazi, Ebrahim Faghihloo, Abolfazl Akbari. Role of the VEGF in virus‐associated cancers. Reviews in Medical Virology 2024; 34(1) doi: 10.1002/rmv.2493
|
38 |
T.B. Deramaudt, C. Dill, M. Bonay. Regulation of oxidative stress by Nrf2 in the pathophysiology of infectious diseases. Médecine et Maladies Infectieuses 2013; 43(3): 100 doi: 10.1016/j.medmal.2013.02.004
|
39 |
Agustin F. Fernandez, Cecilia Rosales, Pilar Lopez-Nieva, Osvaldo Graña, Esteban Ballestar, Santiago Ropero, Jesus Espada, Sonia A. Melo, Amaia Lujambio, Mario F. Fraga, Irene Pino, Biola Javierre, Francisco J. Carmona, Francesco Acquadro, Renske D.M. Steenbergen, Peter J.F. Snijders, Chris J. Meijer, Pascal Pineau, Anne Dejean, Belen Lloveras, Gabriel Capella, Josep Quer, Maria Buti, Juan-Ignacio Esteban, Helena Allende, Francisco Rodriguez-Frias, Xavier Castellsague, Janos Minarovits, Jordi Ponce, Daniela Capello, Gianluca Gaidano, Juan Cruz Cigudosa, Gonzalo Gomez-Lopez, David G. Pisano, Alfonso Valencia, Miguel Angel Piris, Francesc X. Bosch, Ellen Cahir-McFarland, Elliott Kieff, Manel Esteller. The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Research 2009; 19(3): 438 doi: 10.1101/gr.083550.108
|
40 |
Chien-Heng Shen, Shui-Yi Tung, Wen-Shih Huang, Chien-Chang Lu, Ko-Chao Lee, Yung-Yu Hsieh, Pey-Jium Chang, Hwey-Fang Liang, Jiann-Hwa Chen, Tseng-Hsi Lin, Meng Chiao Hsieh, Hsing-Chun Kuo. Exploring the effects of tert-butylhydroperoxide induced liver injury using proteomic approach. Toxicology 2014; 316: 61 doi: 10.1016/j.tox.2013.12.007
|
41 |
Xuefeng Shan, Min Ren, Ke Chen, Ailong Huang, Hua Tang. Regulation of the microRNA processor DGCR8 by hepatitis B virus proteins via the transcription factor YY1. Archives of Virology 2015; 160(3): 795 doi: 10.1007/s00705-014-2286-x
|
42 |
Andreas C W Jenke, Kai O Hensel, Andreas Klein, Lisa Willuhn, Susanna Prax, Patrick P Weil, Theodor Winkler, Timo Deba, Valerie Orth, Armin Baiker, Stefan Wirth, Jan Postberg. Restitution of gene expression and histone acetylation signatures altered by hepatitis B virus through antiviral microRNA-like molecules in nontransformed murine hepatocytes. Clinical Epigenetics 2014; 6(1) doi: 10.1186/1868-7083-6-26
|
43 |
A F Fernandez, M Esteller. Viral epigenomes in human tumorigenesis. Oncogene 2010; 29(10): 1405 doi: 10.1038/onc.2009.517
|
44 |
Christoph Seeger, William S. Mason, Michael M.C. Lai. The Liver. 2020; : 793 doi: 10.1002/9781119436812.ch62
|
45 |
Ying-Hui Shi, Chang-He Shi. Molecular characteristics and stages of chronic hepatitis B virus infection. World Journal of Gastroenterology 2009; 15(25): 3099-3105 doi: 10.3748/wjg.15.3099
|
46 |
E-H Park, S S Koh, R Srisuttee, I-R Cho, H-J Min, B H Jhun, Y-S Lee, K L Jang, C-H Kim, R N Johnston, Y-H Chung. Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells. Cancer Gene Therapy 2009; 16(5): 453 doi: 10.1038/cgt.2008.95
|
47 |
C. Bart Rountree, Wei Ding, Lina He, Bangyan Stiles. Expansion of CD133-Expressing Liver Cancer Stem Cells in Liver-Specific Phosphatase and Tensin Homolog Deleted on Chromosome 10-Deleted Mice. Stem Cells 2009; 27(2): 290 doi: 10.1634/stemcells.2008-0332
|
48 |
Bin Cheng, Xiaorong Guo, Yaochu Zheng, Ying Wang, Chunyan Liu, Peiyuan Li. The effects of HBx gene on the expression of DNA repair enzymes hOGG1 and hMYHα mRNA in HepG2 cells. Journal of Huazhong University of Science and Technology [Medical Sciences] 2009; 29(2): 187 doi: 10.1007/s11596-009-0210-5
|
49 |
Sung Soo Kang, Hyun Ah Cho, Jin-Seok Kim. Biodistribution and improved anticancer effect of NIK-siRNA in combination with 5-FU for hepatocellular carcinoma. Archives of Pharmacal Research 2011; 34(1): 79 doi: 10.1007/s12272-011-0109-0
|
50 |
Christoph Seeger, Michael M. C. Lai, William S. Mason. The Liver. 2009; : 807 doi: 10.1002/9780470747919.ch50
|
51 |
Tri M. Bui-Nguyen, Suresh B. Pakala, Divijendranatha Reddy Sirigiri, Emil Martin, Ferid Murad, Rakesh Kumar. Stimulation of Inducible Nitric Oxide by Hepatitis B Virus Transactivator Protein HBx Requires MTA1 Coregulator. Journal of Biological Chemistry 2010; 285(10): 6980 doi: 10.1074/jbc.M109.065987
|
52 |
Zdenko Herceg, Anupam Paliwal. HBV protein as a double-barrel shot-gun targets epigenetic landscape in liver cancer. Journal of Hepatology 2009; 50(2): 252 doi: 10.1016/j.jhep.2008.11.013
|
53 |
Paulina Niedźwiedzka-Rystwej, Ewelina Grywalska, Rafał Hrynkiewicz, Mikołaj Wołącewicz, Rafał Becht, Jacek Roliński. The Double-Edged Sword Role of Viruses in Gastric Cancer. Cancers 2020; 12(6): 1680 doi: 10.3390/cancers12061680
|
54 |
Asghar Abdoli, Mohsen Nakhaie, Neda Feizi, Ali Salimi Jeda, Amitis Ramezani. Harmonized Autophagy Versus Full-Fledged Hepatitis B Virus: Victorious or Defeated. Viral Immunology 2019; 32(8): 322 doi: 10.1089/vim.2019.0042
|
55 |
Daniela Bender, Eberhard Hildt. Effect of Hepatitis Viruses on the Nrf2/Keap1-Signaling Pathway and Its Impact on Viral Replication and Pathogenesis. International Journal of Molecular Sciences 2019; 20(18): 4659 doi: 10.3390/ijms20184659
|
56 |
Yang Liu, Zhong Hua Zhao, Xiao Qin Lv, Yu Wei Tang, Min Cao, Qin Xiang, Yue Wu, Hua Tang Zhang, Guo Qi Lai. Precise analysis of the effect of basal core promoter/precore mutations on the main phenotype of chronic hepatitis B in mouse models. Journal of Medical Virology 2020; 92(12): 3412 doi: 10.1002/jmv.26025
|
57 |
I. J. Cho, S. H. Ki, C. Brooks, S. G. Kim. Role of hepatitis B virus X repression of C/EBPβ activity in the down-regulation of glutathioneS-transferase A2 gene: implications in other phase II detoxifying enzyme expression. Xenobiotica 2009; 39(2): 182 doi: 10.1080/00498250802549808
|
58 |
A. A. Al‐Qahtani, M. R. Al‐Anazi, N. Nazir, K. Wani, A. A. Abdo, F. M. Sanai, M. Q. Khan, H. I. Al‐Ashgar, A. Albenmousa, W. K. Al‐hamoudi, K. A. Alswat, M. N. Al‐Ahdal. Association of single nucleotide polymorphisms in microRNAs with susceptibility to hepatitis B virus infection and HBV‐related liver complications: A study in a Saudi Arabian population. Journal of Viral Hepatitis 2017; 24(12): 1132 doi: 10.1111/jvh.12749
|
59 |
Fadi ABU BAKER, Yael KOPELMAN, Randa TAHER, Saif ABU MUCH, Ilan GREEN, Amir MARI, Yana DAVIDOV, Ziv BEN-ARI, Ariel ISRAEL. Hepatitis B virus infection and risk of colorectal cancer: a large, population-based cohort study from Israel. Minerva Medica 2024; 115(2) doi: 10.23736/S0026-4806.23.08964-4
|
60 |
Neung Hwa Park, Young-Hwa Chung. Molecular Mechanisms of Hepatitis B Virus-associated Hepatocellular Carcinoma. The Korean Journal of Hepatology 2007; 13(3): 320 doi: 10.3350/kjhep.2007.13.3.320
|
61 |
Roberta Schmieder, Florian Puehler, Roland Neuhaus, Maria Kissel, Alex A Adjei, Jeffrey N Miner, Dominik Mumberg, Karl Ziegelbauer, Arne Scholz. Allosteric MEK1/2 Inhibitor Refametinib (BAY 86-9766) in Combination with Sorafenib Exhibits Antitumor Activity in Preclinical Murine and Rat Models of Hepatocellular Carcinoma. Neoplasia 2013; 15(10): 1161 doi: 10.1593/neo.13812
|
62 |
Celine Van den Broeke, Maria Radu, Jonathan Chernoff, Herman W. Favoreel. An emerging role for p21-activated kinases (Paks) in viral infections. Trends in Cell Biology 2010; 20(3): 160 doi: 10.1016/j.tcb.2009.12.005
|
63 |
Li‐Shuai Qu, Hai‐Feng Zhang. Significance of viral status on prognosis of hepatitis B‐related hepatocellular carcinoma after curative resection in East Asia. Hepatology Research 2016; 46(1): 40 doi: 10.1111/hepr.12523
|
64 |
En-Qiang Chen, Fei-Jun Huang, Ling-Li He, Lang Bai, Li-Chun Wang, Tao-You Zhou, Xue-Zhong Lei, Cong Liu, Hong Tang. Histological Changes in Chinese Chronic Hepatitis B Patients with ALT Lower Than Two Times Upper Limits of Normal. Digestive Diseases and Sciences 2010; 55(2): 432 doi: 10.1007/s10620-009-0724-5
|
65 |
Xiuxiu Sang, Ruilin Wang, Yanzhong Han, Cong'en Zhang, Honghui Shen, Zhirui Yang, Yin Xiong, Huimin Liu, Shijing Liu, Ruisheng Li, Ruichuang Yang, Jiabo Wang, Xuejun Wang, Zhaofang Bai, Xiaohe Xiao. T cell--associated immunoregulation and antiviral effect of oxymatrine in hydrodynamic injection HBV mouse model. Acta Pharmaceutica Sinica B 2017; 7(3): 311 doi: 10.1016/j.apsb.2017.02.005
|
66 |
Krisztina Hagymási, Zsolt Tulassay. Epidemiology, risk factors and molecular pathogenesis of primary liver cancer. Orvosi Hetilap 2008; 149(12): 541 doi: 10.1556/oh.2008.28313
|
67 |
Natalia Freitas, Tetyana Lukash, Louise Rodrigues, Sam Litwin, Bhaskar V. Kallakury, Stephan Menne, Severin O. Gudima, G. McFadden. Infection Patterns Induced in Naive Adult Woodchucks by Virions of Woodchuck Hepatitis Virus Collected during either the Acute or Chronic Phase of Infection. Journal of Virology 2015; 89(17): 8749 doi: 10.1128/JVI.00984-15
|
68 |
Naoko Matsubara, Osamu Kusano, Yasuhiro Sugamata, Tetsuo Itoh, Masaaki Mizuii, Junko Tanaka, Hiroshi Yoshizawa. A novel hepatitis B virus surface antigen immunoassay as sensitive as hepatitis B virus nucleic acid testing in detecting early infection. Transfusion 2009; 49(3): 585 doi: 10.1111/j.1537-2995.2008.02026.x
|
69 |
Dian Yin, Yilang Wang, Wenli Sai, Liang Zhang, Yajun Miao, Lili Cao, Xiaolu Zhai, Xiu Feng, Li Yang. HBx-induced miR-21 suppresses cell apoptosis in hepatocellular carcinoma by targeting interleukin-12. Oncology Reports 2016; 36(4): 2305 doi: 10.3892/or.2016.5026
|
70 |
Nian Ma, Dipayan Bose, Erle S. Robertson. Reference Module in Biomedical Sciences. 2024; doi: 10.1016/B978-0-323-95488-4.00114-5
|
71 |
Shuji Nambu, Teiichi Terasaki, Yoshinari Atarashi, Kazuhiro Matsui, Kazuhiro Tsukada. A case of liver cirrhosis type B accompanied by hepatocellular carcinoma under lamivudine and adefovir treatment. Kanzo 2007; 48(9): 429 doi: 10.2957/kanzo.48.429
|
72 |
Ketan Kulkarni, Ira M. Jacobson, Bud C. Tennant. The Role of the Woodchuck Model in the Treatment of Hepatitis B Virus Infection. Clinics in Liver Disease 2007; 11(4): 707 doi: 10.1016/j.cld.2007.08.012
|
73 |
Louise Rodrigues, Natalia Freitas, Bhaskar V. Kallakury, Stephan Menne, Severin O. Gudima, G. McFadden. Superinfection with Woodchuck Hepatitis Virus Strain WHVNY of Livers Chronically Infected with Strain WHV7. Journal of Virology 2015; 89(1): 384 doi: 10.1128/JVI.02361-14
|
74 |
Teresa Pollicino, Irene Cacciola, Francesca Saffioti, Giovanni Raimondo. Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications. Journal of Hepatology 2014; 61(2): 408 doi: 10.1016/j.jhep.2014.04.041
|
75 |
SHINPEI TATEIWA, YOSHIHIKO YANO, YASUSHI SEO, AKIRA MIKI, KAWANO YUUKI, TAKESHI AZUMA, YOSHITAKE HAYASHI. Clinical significance of hepatitis B virus-DNA in hepatocellular carcinoma negative for hepatitis B virus surface antigen. Experimental and Therapeutic Medicine 2010; 1(2): 343 doi: 10.3892/etm_00000053
|
76 |
Gerhard Meisenberg, William H. Simmons. Principles of Medical Biochemistry. 2012; : 307 doi: 10.1016/B978-0-323-07155-0.00018-6
|
77 |
Qingbin Liu, Xiangyu Zhang, Jingjing Qi, Xinchen Tian, Eva Dovjak, Jiaqi Zhang, Honghuan Du, Ni Zhang, Jing Zhao, Yiming Zhang, Lijuan Wang, Yangang Wei, Chenqiao Liu, Ruikun Qian, Longquan Xiang, Weiyang Li, Peng Xiu, Changlin Ma, Yong Yu, Shulong Jiang. Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC. Hepatology 2024; doi: 10.1097/HEP.0000000000000962
|
78 |
Shulin Xia, Jiachen Ding, Zhenhua Zhang, Xu Li, Jianhe Gan, Xiaomin He. Cluster of Differentiation 24 Polymorphism Has No Significant Association with Chronic Hepatitis B Virus Infection in the Chinese Han Population: A Family-Based Association Study. Infection and Drug Resistance 2022; : 4837 doi: 10.2147/IDR.S368392
|
79 |
B. Kara, F. Doran, I. O. Kara, H. Akkiz, M. Sandikci. Expression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role?. International Journal of Clinical Practice 2008; 62(8): 1206 doi: 10.1111/j.1742-1241.2007.01675.x
|
80 |
Francesca Guerrieri, Laura Belloni, Natalia Pediconi, Massimo Levrero. Hepatitis B Virus in Human Diseases. Molecular and Translational Medicine 2016; : 95 doi: 10.1007/978-3-319-22330-8_5
|
81 |
A Arzumanyan, T Friedman, E Kotei, I O L Ng, Z Lian, M A Feitelson. Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer. Oncogene 2012; 31(5): 563 doi: 10.1038/onc.2011.255
|
82 |
Hiroji Shinkawa, Takuya Nakai, Akihiro Tamori, Hiromu Tanaka, Shigekazu Takemura, Kazuki Ohba, Takahiro Uenishi, Masao Ogawa, Satoshi Yamamoto, Seikan Hai, Tsuyoshi Ichikawa, Shintaro Kodai, Kazuhiro Hirohashi, Kenichi Wakasa, Shoji Kubo. Hepatocellular carcinoma (HCC) recurring 10 years after clearance of hepatitis B surface antigen and 20 years after resection of hepatitis B virus-related HCC. International Journal of Clinical Oncology 2008; 13(6): 562 doi: 10.1007/s10147-008-0785-z
|
83 |
Yuanyan Wei, Dan Liu, Fengbiao Zhou, Yuqing Ge, Jiejie Xu, Xiaojing Yun, Jianxin Gu, Jianhai Jiang. Identification of β-1,4-galactosyltransferase I as a target gene of HBx-induced cell cycle progression of hepatoma cell. Journal of Hepatology 2008; 49(6): 1029 doi: 10.1016/j.jhep.2008.09.003
|
84 |
Myung Hee Yoon, Young Il Choi, Kwang Kuk Park, Dong Hoon Shin, Chung Han Lee. Risk Factors for Intrahepatic Recurrence after Resection of Hepatocellular Carcinomas in Patients with Hepatitis B Virus Infection. Korean Journal of Hepato-Biliary-Pancreatic Surgery 2011; 15(2): 83 doi: 10.14701/kjhbps.2011.15.2.83
|
85 |
Gang Huang, Eric C. H. Lai, Wan Yee Lau, Wei-ping Zhou, Feng Shen, Ze-ya Pan, Si-yuan Fu, Meng-chao Wu. Posthepatectomy HBV Reactivation in Hepatitis B–Related Hepatocellular Carcinoma Influences Postoperative Survival in Patients With Preoperative Low HBV-DNA Levels. Annals of Surgery 2013; 257(3): 490 doi: 10.1097/SLA.0b013e318262b218
|
86 |
Xiaoping Wang, Qiaoxia Wang, Huanping Lin, Sanzhong Li, Lijun Sun, Yixin Yang. HSP72 and gp96 in gastroenterological cancers. Clinica Chimica Acta 2013; 417: 73 doi: 10.1016/j.cca.2012.12.017
|
87 |
Hans-Jürgen Netter, Shau-Feng Chang, Michael Bruns. Host-Range and Pathogenicity of Hepatitis B Viruses. Future Virology 2008; 3(1): 83 doi: 10.2217/17460794.3.1.83
|
88 |
Hans Helmut Niller, Eva Ay, Ferenc Banati, Anett Demcsák, Maria Takacs, Janos Minarovits. Wild type HBx and truncated HBx: Pleiotropic regulators driving sequential genetic and epigenetic steps of hepatocarcinogenesis and progression of HBV‐associated neoplasms. Reviews in Medical Virology 2016; 26(1): 57 doi: 10.1002/rmv.1864
|
89 |
Gesa von Olshausen, Maria Quasdorff, Romina Bester, Silke Arzberger, Chunkyu Ko, Maarten van de Klundert, Ke Zhang, Margarete Odenthal, Marc Ringelhan, Carien M. Niessen, Ulrike Protzer. Hepatitis B virus promotes β-catenin-signalling and disassembly of adherens junctions in a Src kinase dependent fashion. Oncotarget 2018; 9(74): 33947 doi: 10.18632/oncotarget.26103
|
90 |
Tamara Severi, Hannah van Malenstein, Chris Verslype, Jos F van Pelt. Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets. Acta Pharmacologica Sinica 2010; 31(11): 1409 doi: 10.1038/aps.2010.142
|
91 |
Feng-ze Wang, Hong-rong Fei, Li-hui Lian, Jian-mei Wang, Yu-yu Qiu. Hepatitis B x-interacting protein induces HepG2 cell proliferation through activation of the phosphatidylinositol 3-kinase/Akt pathway. Experimental Biology and Medicine 2011; 236(1): 62 doi: 10.1258/ebm.2010.010179
|
92 |
Mahua Sinha, Keerthana Sundar, C. S. Premalata, Vikas Asati, Alka Murali, Akhilesh Kumar Bajpai, Sravanthi Davuluri, Kshitish K. Acharya, K. C. Lakshmaiah, Govind Babu K., Linu A. Jacob, Dharam Nandan, Dinesh Velayutham, Sibnarayan Datta, R. S. Jayshree. Pro-oncogenic, intra host viral quasispecies in Diffuse large B cell lymphoma patients with occult Hepatitis B Virus infection. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-51157-1
|
93 |
Zebao He, Jiansheng Zhu, Jinggang Mo, Haihong Zhao, Qiuyue Chen. HBV DNA integrates into upregulated ZBTB20 in patients with hepatocellular carcinoma. Molecular Medicine Reports 2020; doi: 10.3892/mmr.2020.11074
|
94 |
John M. Vierling. The Immunology of Hepatitis B. Clinics in Liver Disease 2007; 11(4): 727 doi: 10.1016/j.cld.2007.08.001
|
95 |
Sebastian Robert Barthel, Regina Medvedev, Thekla Heinrich, Sarah Manon Büchner, Nadja Kettern, Eberhard Hildt. Hepatitis B virus inhibits insulin receptor signaling and impairs liver regeneration via intracellular retention of the insulin receptor. Cellular and Molecular Life Sciences 2016; 73(21): 4121 doi: 10.1007/s00018-016-2259-1
|
96 |
Ruchi Shukla, Jiping Yue, Maha Siouda, Tarik Gheit, Olivier Hantz, Philippe Merle, Fabien Zoulim, Vladimir Krutovskikh, Massimo Tommasino, Bakary S. Sylla. Proinflammatory cytokine TNF-α increases the stability of hepatitis B virus X protein through NF-κB signaling. Carcinogenesis 2011; 32(7): 978 doi: 10.1093/carcin/bgr057
|
97 |
Hans Helmut Niller, Ferenc Banati, Eva Ay, Janos Minarovits. Patho-Epigenetics of Disease. 2012; : 179 doi: 10.1007/978-1-4614-3345-3_8
|
98 |
Bing-Fang Chen. Hepatitis B virus pre-S/S variants in liver diseases. World Journal of Gastroenterology 2018; 24(14): 1507-1520 doi: 10.3748/wjg.v24.i14.1507
|
99 |
Inken Wierstra. . Advances in Cancer Research 2013; 119: 191 doi: 10.1016/B978-0-12-407190-2.00016-2
|
100 |
Jin-Shui Pan, Jia-Yan Cai, Chen-Xi Xie, Fei Zhou, Zhi-Ping Zhang, Jing Dong, Hong-Zhi Xu, Hua-Xiu Shi, Jian-Lin Ren. Interacting with HBsAg compromises resistance of jumping translocation breakpoint protein to ultraviolet radiation-induced apoptosis in 293FT cells. Cancer Letters 2009; 285(2): 151 doi: 10.1016/j.canlet.2009.05.009
|
101 |
Pengyuan Yang, Qi-Jing Li, Yuxiong Feng, Yun Zhang, Geoffrey J. Markowitz, Shanglei Ning, Yuezhen Deng, Jiangsha Zhao, Shan Jiang, Yunfei Yuan, Hong-Yang Wang, Shu-Qun Cheng, Dong Xie, Xiao-Fan Wang. TGF-β-miR-34a-CCL22 Signaling-Induced Treg Cell Recruitment Promotes Venous Metastases of HBV-Positive Hepatocellular Carcinoma. Cancer Cell 2012; 22(3): 291 doi: 10.1016/j.ccr.2012.07.023
|
102 |
Lee Jin Lim, Samuel Y.S. Wong, Feiyang Huang, Sheng Lim, Samuel S. Chong, London Lucien Ooi, Oi Lian Kon, Caroline G. Lee. Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma. Cancer Research 2019; 79(20): 5131 doi: 10.1158/0008-5472.CAN-19-0255
|
103 |
Peng Wang, Xinhui Wang, Xiaoli Liu, Fengna Yan, Huiwen Yan, Dongdong Zhou, Lihua Yu, Xianbo Wang, Zhiyun Yang. Primary non-response to antiviral therapy affects the prognosis of hepatitis B virus-related hepatocellular carcinoma. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11059-y
|
104 |
Gang Huang, Wan Yee Lau, Zhen-Guang Wang, Ze-Ya Pan, Sheng-Xian Yuan, Feng Shen, Wei-Ping Zhou, Meng-Chao Wu. Antiviral Therapy Improves Postoperative Survival in Patients With Hepatocellular Carcinoma. Annals of Surgery 2015; 261(1): 56 doi: 10.1097/SLA.0000000000000858
|
105 |
Liang Wang, Zhi-jun Wu-Xiao, Xiao-qin Chen, Yu-jing Zhang, Yue Lu, Zhong-jun Xia. Hepatitis B virus infection correlates with poor prognosis of extranodal natural killer/T cell lymphoma. Leukemia & Lymphoma 2015; 56(4): 936 doi: 10.3109/10428194.2014.953146
|
106 |
Vanessa Meier-Stephenson, William T. R. Bremner, Chimone S. Dalton, Guido Van Marle, Carla S. Coffin, Trushar R. Patel. Comprehensive Analysis of Hepatitis B Virus Promoter Region Mutations. Viruses 2018; 10(11): 603 doi: 10.3390/v10110603
|
107 |
Ian H. Frazer, Doug R. Lowy, John T. Schiller. Prevention of cancer through immunization: Prospects and challenges for the 21st century. European Journal of Immunology 2007; 37(S1): S148 doi: 10.1002/eji.200737820
|
108 |
Fengze Wang, Hongrong Fei, Bing Qi, Shutong Yao, Zhengyao Chang. Overexpression of hepatitis B x-interacting protein in HepG2 cells enhances tumor-induced angiogenesis. Molecular and Cellular Biochemistry 2012; 364(1-2): 165 doi: 10.1007/s11010-011-1215-5
|
109 |
Douglas Dieterich, Camilla Graham, Su Wang, Paul Kwo, Young-Suk Lim, Chun-Jen Liu, Kosh Agarwal, Mark Sulkowski. It Is Time for a Simplified Approach to Hepatitis B Elimination. Gastro Hep Advances 2023; 2(2): 209 doi: 10.1016/j.gastha.2022.10.004
|
110 |
Андрей Бушманов, Andrey Bushmanov, О. Клементьева, O. Klement'eva, А. Лабушкина, A. Labushkina, А. Тултаев, A. Tultaev, В. Корсунский, V. Korsunskiy, О. Кузнецова, O. Kuznetsova. Actual Problems and Perspectives of the Application of Nuclear Medicine Techniques in the Diagnostic and Treatment of Hepatocellular Carcinoma: Analytical Review. Medical Radiology and radiation safety 2019; 64(5): 58 doi: 10.12737/1024-6177-2019-64-5-58-68
|
111 |
Wing-Kin Sung, Yiwei Lu, Charlie W.H. Lee, Dongwei Zhang, Mostafa Ronaghi, Caroline G.L. Lee. Deregulated Direct Targets of the Hepatitis B Virus (HBV) Protein, HBx, Identified through Chromatin Immunoprecipitation and Expression Microarray Profiling. Journal of Biological Chemistry 2009; 284(33): 21941 doi: 10.1074/jbc.M109.014563
|
112 |
Marie Gauthier, Bertrand Bonnaud, Maud Arsac, Fabien Lavocat, Jérôme Maisetti, Alan Kay, François Simon, Fabien Zoulim, Guy Vernet. Microarray for Hepatitis B Virus Genotyping and Detection of 994 Mutations along the Genome. Journal of Clinical Microbiology 2010; 48(11): 4207 doi: 10.1128/JCM.00344-10
|
113 |
Teresa Pollicino, Lemonica Koumbi. Role natural killer group 2D-ligand interactions in hepatitis B infection. World Journal of Hepatology 2015; 7(6): 819-824 doi: 10.4254/wjh.v7.i6.819
|
114 |
Xiaojing Zhou, Hongfei Wei, Peng Sun, Xiuli Wu, Min Wan, Peng Zhang, Sheng Guo, Tiesuo Zhao, Yongli Yu, Liying Wang. Recombinant Hepatitis B Virus Surface Antigen Formulated with B-Type CpG Oligodeoxynucleotide Induces Therapeutic Immunity Against Hepatitis B Virus Surface Antigen-Expressing Liver Cancer Cells in Mice. Cancer Biotherapy and Radiopharmaceuticals 2012; 27(4): 234 doi: 10.1089/cbr.2011.1127
|
115 |
Shu-Xiang Wu, Shuang-Shuang Ye, Yu-Xiang Hong, Yan Chen, Biao Wang, Xin-Jian Lin, Xu Lin, J.-H. James Ou. Hepatitis B Virus Small Envelope Protein Promotes Hepatocellular Carcinoma Angiogenesis via Endoplasmic Reticulum Stress Signaling To Upregulate the Expression of Vascular Endothelial Growth Factor A. Journal of Virology 2022; 96(4) doi: 10.1128/jvi.01975-21
|
116 |
Gautam Sethi, Snehajyoti Chatterjee, Peramaiyan Rajendran, Feng Li, Muthu K Shanmugam, Kwong Fai Wong, Alan Prem Kumar, Parijat Senapati, Amit K Behera, Kam Man Hui, Jeelan Basha, Nagashayana Natesh, John M Luk, Tapas K Kundu. Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo. Molecular Cancer 2014; 13(1) doi: 10.1186/1476-4598-13-66
|
117 |
Ahmed A. Al-Qahtani, Mashael R. Al-Anazi, Nyla Nazir, Rohit Ghai, Ayman A. Abdo, Faisal M. Sanai, Waleed K. Al-Hamoudi, Khalid A. Alswat, Hamad I. Al-Ashgar, Mohammed Q. Khan, Ali Albenmousa, Damian Dela Cruz, Marie Fe F. Bohol, Mohammed N. Al-Ahdal. Hepatitis B virus (HBV) X gene mutations and their association with liver disease progression in HBV-infected patients. Oncotarget 2017; 8(62): 105115 doi: 10.18632/oncotarget.22428
|
118 |
Xiaochen Tian, Jinjun Li, Zhang-Mei Ma, Chao Zhao, Da-Fang Wan, Yu-Mei Wen. Role of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1. Journal of Experimental & Clinical Cancer Research 2009; 28(1) doi: 10.1186/1756-9966-28-58
|
119 |
Ashutosh Tiwari, Anurag Sankhyan, Navin Khanna, Subrata Sinha. Enhanced periplasmic expression of high affinity humanized scFv against Hepatitis B surface antigen by codon optimization. Protein Expression and Purification 2010; 74(2): 272 doi: 10.1016/j.pep.2010.06.006
|
120 |
Chao Zhao, Wei Zhang, Xiaochen Tian, Caiyun Fang, Haojie Lu, Zhenghong Yuan, Pengyuan Yang, Yumei Wen. Proteomic analysis of cell lines expressing small hepatitis B surface antigen revealed decreased glucose‐regulated protein 78 kDa expression in association with higher susceptibility to apoptosis. Journal of Medical Virology 2010; 82(1): 14 doi: 10.1002/jmv.21654
|
121 |
Julianne Bayliss, Lucy Lim, Alexander J.V. Thompson, Paul Desmond, Peter Angus, Stephen Locarnini, Peter A. Revill. Hepatitis B virus splicing is enhanced prior to development of hepatocellular carcinoma. Journal of Hepatology 2013; 59(5): 1022 doi: 10.1016/j.jhep.2013.06.018
|
122 |
Natalia Freitas, Tetyana Lukash, Megan Dudek, Sam Litwin, Stephan Menne, Severin O. Gudima. Capacity of a natural strain of woodchuck hepatitis virus, WHVNY, to induce acute infection in naive adult woodchucks. Virus Research 2015; 205: 12 doi: 10.1016/j.virusres.2015.05.003
|
123 |
S Kiruthika, Ruchika Bhat, B Jayaram, Perumal Vivekanandan. A small molecule targeting hepatitis B surface antigen inhibits clinically relevant drug-resistant hepatitis B virus. Journal of Antimicrobial Chemotherapy 2022; 77(8): 2120 doi: 10.1093/jac/dkac148
|
124 |
Suk Kyun Hong, Xue‐Li Jin, Sanggyun Suh, Su young Hong, Kwangpyo Hong, Eui Soo Han, Jeong‐Moo Lee, YoungRok Choi, Nam‐Joon Yi, Kwang‐Woong Lee, Kyung‐Suk Suh. Different Risk Factors for Early and Late Recurrence After Curative Resection of Hepatocellular Carcinoma. World Journal of Surgery 2022; 46(1): 197 doi: 10.1007/s00268-021-06308-9
|
125 |
Stephanie Schädler, Eberhard Hildt. HBV Life Cycle: Entry and Morphogenesis. Viruses 2009; 1(2): 185 doi: 10.3390/v1020185
|
126 |
|
127 |
Ivan F. N. Hung, Ronnie T. P. Poon, Ching-Lung Lai, James Fung, Sheung-Tat Fan, Man-Fung Yuen. Recurrence of Hepatitis B-Related Hepatocellular Carcinoma Is Associated With High Viral Load at the Time of Resection. The American Journal of Gastroenterology 2008; 103(7): 1663 doi: 10.1111/j.1572-0241.2008.01872.x
|
128 |
Shengxi Wu, Chengying Yang, Sheng Guo, Lei Fei, Na Luo, Xiaolan Fu, Yongwen Chen, Yuzhang Wu. Stimulation of B7-H1 in Hepatocarcinoma Cells by Hepatitis B virus X Antigen. Immunological Investigations 2010; 39(7): 754 doi: 10.3109/08820139.2010.494193
|
129 |
Han Bai, Hongbo Liu, Xiaokai Chen, Chan Xu, Xiaoguang Dou. Influence of Age and HBeAg Status on the Correlation Between HBV DNA and Hepatic Inflammation and Fibrosis in Chronic Hepatitis B Patients. Digestive Diseases and Sciences 2013; 58(5): 1355 doi: 10.1007/s10620-012-2479-7
|
130 |
Weili Qi, Junyi Shen, Junlong Dai, Youwei Wu, Yu Zhang, Shusheng Leng, Fengwei Gao, Shun Ran, Wei Peng, Xiaoyun Zhang, Tianfu Wen, Chuan Li. Comparison of nucleoside and nucleotide analogs in the recurrence of hepatitis B virus‐related hepatocellular carcinoma after surgical resection: A multicenter study. Cancer Medicine 2021; 10(23): 8421 doi: 10.1002/cam4.4348
|
131 |
Neung Hwa Park, Il Han Song, Young-Hwa Chung. Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma. Gut and Liver 2007; 1(2): 101 doi: 10.5009/gnl.2007.1.2.101
|
132 |
Maura Dandri. Epigenetic modulation in chronic hepatitis B virus infection. Seminars in Immunopathology 2020; 42(2): 173 doi: 10.1007/s00281-020-00780-6
|
133 |
Cheng-Ming Lee, Yi-Ping Shih, Cho-Han Wu, Yi-Ming Arthur Chen. Characterization of the 5′ regulatory region of the human Glycine N-methyltransferase gene. Gene 2009; 443(1-2): 151 doi: 10.1016/j.gene.2009.05.001
|
134 |
Serhat Samanci, Muhammet Kosker. Evaluation of hematological parameters in inactive hepatitis B infection; neutrophil to lymphocyte ratio and mean platelet volume. Medical Journal of the Russian Federation 2022; 28(2): 141 doi: 10.17816/medjrf109318
|
135 |
XUEMEI QIU, LIHUA ZHANG, SEN LU, YUNWEI SONG, YINGBIN LAO, JIAOJIAO HU, HONG FAN. Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation. Oncology Reports 2014; 31(1): 202 doi: 10.3892/or.2013.2848
|
136 |
Xiaosong Li, Junke Zhu, Guoqi Lai, Lei Yan, Jieli Hu, Juan Chen, Ni Tang, Ailong Huang. The Infection Efficiency and Replication Ability of Circularized HBV DNA Optimized the Linear HBV DNA in Vitro and in Vivo. International Journal of Molecular Sciences 2015; 16(3): 5141 doi: 10.3390/ijms16035141
|
137 |
Fang Wei, Xiao-Xia Cheng, John Zhao Xue, Shao-An Xue. Emerging Strategies in TCR-Engineered T Cells. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.850358
|
138 |
Surya Agung Priyambada, Ryo Misaki, Toru Okamoto, Yuta Okamoto, Takao Ohashi, Keiji Ueda, Yoshiharu Matsuura, Kazuhito Fujiyama. Cell surface N-glycan alteration in HepAD38 cell lines expressing Hepatitis B virus. Virus Research 2017; 238: 101 doi: 10.1016/j.virusres.2017.06.003
|
139 |
Stuart K. Roberts, Ammar Majeed, William Kemp. Controversies in the Management of Hepatitis B. Clinics in Liver Disease 2021; 25(4): 785 doi: 10.1016/j.cld.2021.06.006
|
140 |
Z. I. Siddiqui, S. R. Farooqui, S. A. Azam, M. Afroz, S. Wajid, S. Parveen, S. N. Kazim. A comparative study of hepatitis B virus X protein mutants K130M, V131I and KV130/131MI to investigate their roles in fibrosis, cirrhosis and hepatocellular carcinoma. Journal of Viral Hepatitis 2017; 24(12): 1121 doi: 10.1111/jvh.12747
|
141 |
Ho Jung An, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Se Hyun Cho, Seung Kew Yoon, June Yeol Han, Keun Ho Lee, Dong Goo Kim, Eun Sun Jung. Sustained low hepatitis B viral load predicts good outcome after curative resection in patients with hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2010; 25(12): 1876 doi: 10.1111/j.1440-1746.2010.06416.x
|
142 |
Yanan Pang, Weixing Guo, Jiaqi Wang, Guixia Xu, Kai Cheng, Guangwen Cao, Mengchao Wu, Shuqun Cheng, Shanrong Liu. Gene copy number variations in the leukocyte genome of hepatocellular carcinoma patients with integrated hepatitis B virus DNA. Oncotarget 2016; 7(7): 8006 doi: 10.18632/oncotarget.6895
|
143 |
S. T. Toh, Y. Jin, L. Liu, J. Wang, F. Babrzadeh, B. Gharizadeh, M. Ronaghi, H. C. Toh, P. K.-H. Chow, A. Y.-F. Chung, L. L.-P.-J. Ooi, C. G.-L. Lee. Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations. Carcinogenesis 2013; 34(4): 787 doi: 10.1093/carcin/bgs406
|
144 |
JING LUO, HAIYAN ZHOU, FAN WANG, XIUMEI XIA, QIAN SUN, RONGHUA WANG, BIN CHENG. The hepatitis B virus X protein downregulates NF-κB signaling pathways through decreasing the Notch signaling pathway in HBx-transformed L02 cells. International Journal of Oncology 2013; 42(5): 1636 doi: 10.3892/ijo.2013.1842
|
145 |
R. Bart Takkenberg, Hans L. Zaaijer, Sandra Menting, Christine J. Weegink, Valeska Terpstra, Marion Cornelissen, Marcel G.W. Dijkgraaf, Peter L.M. Jansen, Hendrik W. Reesink, Marcel G.H.M. Beld. Detection of hepatitis B virus covalently closed circular DNA in paraffin-embedded and cryo-preserved liver biopsies of chronic hepatitis B patients. European Journal of Gastroenterology & Hepatology 2010; 22(8): 952 doi: 10.1097/MEG.0b013e3283376a63
|
146 |
Vijay Pandyarajan, Rajalakshmi Govalan, Ju Dong Yang. Risk Factors and Biomarkers for Chronic Hepatitis B Associated Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(2): 479 doi: 10.3390/ijms22020479
|
147 |
Dongling Li, Linghua Zheng, Lei Jin, Yuesu Zhou, Haiying Li, Junliang Fu, Ming Shi, Peishuang Du, Lizhong Wang, Hao Wu, Guo-Yun Chen, Pan Zheng, Yang Liu, Fu-Sheng Wang, Shengdian Wang. CD24 polymorphisms affect risk and progression of chronic hepatitis B virus infection #. Hepatology 2009; 50(3): 735 doi: 10.1002/hep.23047
|
148 |
Yue Zhao, Alexey V. Baldin, Orkhan Isayev, Jens Werner, Andrey A. Zamyatnin, Alexandr V. Bazhin. Cancer Vaccines: Antigen Selection Strategy. Vaccines 2021; 9(2): 85 doi: 10.3390/vaccines9020085
|
149 |
Przemyslaw Zdziarski, Andrzej Gamian. Role of B Cells beyond Antibodies in HBV-Induced Oncogenesis: Fulminant Cancer in Common Variable Immunodeficiency—Clinical and Immunotransplant Implications with a Review of the Literature. Diseases 2024; 12(5): 80 doi: 10.3390/diseases12050080
|
150 |
Michel Neidhart. DNA Methylation and Complex Human Disease. 2016; : 81 doi: 10.1016/B978-0-12-420194-1.00006-3
|
151 |
Tuhin Bhowmik, Bernadette D’Souza, Mohammad N. Uddin, Martin J. D’Souza. Oral delivery of microparticles containing plasmid DNA encoding hepatitis-B surface antigen. Journal of Drug Targeting 2012; 20(4): 364 doi: 10.3109/1061186X.2012.662686
|
152 |
Ashraf Ali, Hany Abdel-Hafiz, Mohd Suhail, Amany Al-Mars, Mohammad Khalid Zakaria, Kaneez Fatima, Sultan Ahmad, Esam Azhar, Adeel Chaudhary, Ishtiaq Qadri. Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma. World Journal of Gastroenterology 2014; 20(30): 10238-10248 doi: 10.3748/wjg.v20.i30.10238
|
153 |
Ning-fu Peng, Le-qun Li, Xiao Qin, Ya Guo, Tao Peng, Kai-yin Xiao, Xi-gang Chen, Yu-feng Yang, Zhi-xiong Su, Bin Chen, Ming Su, Lu-nan Qi. Evaluation of Risk Factors and Clinicopathologic Features for Intrahepatic Cholangiocarcinoma in Southern China: A Possible Role of Hepatitis B Virus. Annals of Surgical Oncology 2011; 18(5): 1258 doi: 10.1245/s10434-010-1458-5
|
154 |
Natalia Freitas, Celso Cunha, Stephan Menne, Severin O. Gudima, G. McFadden. Envelope Proteins Derived from Naturally Integrated Hepatitis B Virus DNA Support Assembly and Release of Infectious Hepatitis Delta Virus Particles. Journal of Virology 2014; 88(10): 5742 doi: 10.1128/JVI.00430-14
|
155 |
Hie-Won L. Hann, Mark Feitelson. Hepatocellular Carcinoma. 2009; : 235 doi: 10.1007/978-1-60327-376-3_7
|
156 |
John T. Schiller, Douglas R. Lowy. Vaccines to Prevent Infections by Oncoviruses. Annual Review of Microbiology 2010; 64(1): 23 doi: 10.1146/annurev.micro.112408.134019
|
157 |
Bin Cheng, Yaochu Zheng, Xiaorong Guo, Ying Wang, Chunyan Liu. Hepatitis B viral X protein alters the biological features and expressions of DNA repair enzymes in LO2 cells. Liver International 2010; 30(2): 319 doi: 10.1111/j.1478-3231.2009.02167.x
|
158 |
Fidel D. Huitzil‐Melendez, Ghassan K. Abou‐Alfa, Michael A. Morse. Malignant Liver Tumors. 2010; : 382 doi: 10.1002/9781444317053.ch32
|
159 |
N. Wang, Y. Zheng, X. Yu, W. Lin, Y. Chen, Q. Jiang. Sex-Modified Effect of Hepatitis B Virus Infection on Mortality From Primary Liver Cancer. American Journal of Epidemiology 2009; 169(8): 990 doi: 10.1093/aje/kwn418
|
160 |
Natalia Freitas, Kenji Abe, Celso Cunha, Stephan Menne, Severin O. Gudima, G. McFadden. Support of the Infectivity of Hepatitis Delta Virus Particles by the Envelope Proteins of Different Genotypes of Hepatitis B Virus. Journal of Virology 2014; 88(11): 6255 doi: 10.1128/JVI.00346-14
|
161 |
T M Bui-Nguyen, S B Pakala, R D Sirigiri, W Xia, M-C Hung, S K Sarin, V Kumar, B L Slagle, R Kumar. NF-κB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBx. Oncogene 2010; 29(8): 1179 doi: 10.1038/onc.2009.404
|
162 |
B.S Anjali Devi, Venugopal Reddy Bovilla, SubbaRao V. Madhunapantula. Current Perspectives in Human Papilloma Virus: Where We are and What We Need?. Biomedical and Pharmacology Journal 2019; 12(04): 1683 doi: 10.13005/bpj/1798
|
163 |
Stephanie Schaedler, Janis Krause, Kiyoshi Himmelsbach, Monica Carvajal-Yepes, Franziska Lieder, Karin Klingel, Michael Nassal, Thomas S. Weiss, Sabine Werner, Eberhard Hildt. Hepatitis B Virus Induces Expression of Antioxidant Response Element-regulated Genes by Activation of Nrf2. Journal of Biological Chemistry 2010; 285(52): 41074 doi: 10.1074/jbc.M110.145862
|
164 |
Carmen Berasain, Maria J. Perugorria, Maria Ujue Latasa, Josefa Castillo, Saioa Goñi, Mónica Santamaría, Jesús Prieto, Matías A. Avila. The Epidermal Growth Factor Receptor: A Link Between Inflammation and Liver Cancer. Experimental Biology and Medicine 2009; 234(7): 713 doi: 10.3181/0901-MR-12
|
165 |
Yoshiyuki Watanabe, Hiroyuki Yamamoto, Ritsuko Oikawa, Minoru Toyota, Masakazu Yamamoto, Norihiro Kokudo, Shinji Tanaka, Shigeki Arii, Hiroshi Yotsuyanagi, Kazuhiko Koike, Fumio Itoh. DNA methylation at hepatitis B viral integrants is associated with methylation at flanking human genomic sequences. Genome Research 2015; 25(3): 328 doi: 10.1101/gr.175240.114
|
166 |
Hang Zhang, Lian-Ying Wu, Shuai Zhang, Li-Yan Qiu, Nan Li, Xuan Zhang, Xue-Zhi Zhang, Chang-Liang Shan, Li-Hong Ye, Xiao-Dong Zhang, Xin-yuan Guan. Anti‐Hepatitis B Virus X Protein in Sera Is One of the Markers of Development of Liver Cirrhosis and Liver Cancer Mediated by HBV. BioMed Research International 2009; 2009(1) doi: 10.1155/2009/289068
|
167 |
Bo Hong, Yun Qian, Hong Zhang, Yi-Wen Sang, Lin-Fang Cheng, Qi Wang, Song Gao, Min Zheng, Hang-Ping Yao. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(18): 4538-4546 doi: 10.3748/wjg.v22.i18.4538
|
168 |
|
169 |
Ratakorn Srisuttee, Sang Seok Koh, Waraporn Malilas, Jeong Moon, Il-Rae Cho, Byung Hak Jhun, Yoshiyuki Horio, Young-Hwa Chung. SIRT1 sensitizes hepatocellular carcinoma cells expressing hepatitis B virus X protein to oxidative stress-induced apoptosis. Biochemical and Biophysical Research Communications 2012; 429(1-2): 45 doi: 10.1016/j.bbrc.2012.10.102
|
170 |
Zhi-Jun Su, Jia-Shou Cao, Yan-Fang Wu, Wan-Nan Chen, Xinjian Lin, Yun-Li Wu, Xu Lin. Deubiquitylation of hepatitis B virus X protein (HBx) by ubiquitin-specific peptidase 15 (USP15) increases HBx stability and its transactivation activity. Scientific Reports 2017; 7(1) doi: 10.1038/srep40246
|
171 |
Peter A Revill, Kumar Visvanathan, Stephen A Locarnini. Elucidating the Role of the HBV e Antigen in Manipulating the Innate Immune Response. Future Virology 2015; 10(4): 429 doi: 10.2217/fvl.15.14
|
172 |
Kai O. Hensel, Julio C. Rendon, Maria‐Cristina Navas, Marianne G. Rots, Jan Postberg. Virus–host interplay in hepatitis B virus infection and epigenetic treatment strategies. The FEBS Journal 2017; 284(21): 3550 doi: 10.1111/febs.14094
|
173 |
Yu Jin, Wai Yeow Lee, Soo Ting Toh, Chandana Tennakoon, Han Chong Toh, Pierce Kah-Hoe Chow, Alexander Y.-F. Chung, Samuel S. Chong, London L.-P.-J. Ooi, Wing-Kin Sung, Caroline G.-L. Lee. Comprehensive analysis of transcriptome profiles in hepatocellular carcinoma. Journal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-2025-x
|
174 |
Tsung-Jung Liang, King-Tong Mok, Shiuh-Inn Liu, Shiu-Feng Huang, Nan-Hua Chou, Cheng-Chung Tsai, -Shu I. Chen, Ming-Hsin Yeh, Yu-Chia Chen, Being-Whey Wang. Hepatitis B Genotype C Correlated with Poor Surgical Outcomes for Hepatocellular Carcinoma. Journal of the American College of Surgeons 2010; 211(5): 580 doi: 10.1016/j.jamcollsurg.2010.06.020
|
175 |
Moataz Soliman, Nicholas Guys, Peter Liu, Mariam Moshiri, Christine O. Menias, Vincent M. Mellnick, Hatice Savas, Mohamed Badawy, Khaled M. Elsayes, Ayman H. Gaballah. Multimodality imaging findings of infection-induced tumors. Abdominal Radiology 2022; 47(11): 3930 doi: 10.1007/s00261-022-03651-w
|
176 |
Min Cao, Zhonghua Zhao, Yuwei Tang, Qinglv Wei, Lei Wang, Qin Xiang, Yunmei Zhang, Huatang Zhang, Guoqi Lai. A new hepatitis B virus e antigen-negative strain gene used as a reference sequence in an animal model. Biochemical and Biophysical Research Communications 2018; 496(2): 502 doi: 10.1016/j.bbrc.2018.01.081
|
177 |
Kejia Wang, Zhujun Mao, Li Liu, Ronghua Zhang, Qing Liang, Yaokang Xiong, Wenjun Yuan, Li Wei. Rab17 inhibits the tumourigenic properties of hepatocellular carcinomas via the Erk pathway. Tumor Biology 2015; 36(8): 5815 doi: 10.1007/s13277-015-3251-3
|
178 |
Shaikh Maryam Ghufran, Prachi Sharma, Bornika Roy, Shivani Jaiswal, Mehreen Aftab, Shinjinee Sengupta, Sampa Ghose, Subhrajit Biswas. Transcriptome wide functional analysis of HBx expressing human hepatocytes stimulated with endothelial cell cross-talk. Genomics 2023; 115(4): 110642 doi: 10.1016/j.ygeno.2023.110642
|
179 |
Franz Geisslinger, Angelika M. Vollmar, Karin Bartel. Cancer Patients Have a Higher Risk Regarding COVID-19–and Vice Versa?. Pharmaceuticals 2020; 13(7): 143 doi: 10.3390/ph13070143
|
180 |
Guitian He, Juntao Ding, Yong’e Zhang, Mengting Cai, Jing Yang, William C. Cho, Yadong Zheng. microRNA-21: a key modulator in oncogenic viral infections. RNA Biology 2021; 18(5): 809 doi: 10.1080/15476286.2021.1880756
|
181 |
Ka-Cheung Luk, Jeffrey Gersch, Barbara J. Harris, Vera Holzmayer, Dora Mbanya, Silvia Sauleda, Mary A. Rodgers, Gavin Cloherty. More DNA and RNA of HBV SP1 splice variants are detected in genotypes B and C at low viral replication. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-03304-w
|
182 |
Wenmei Fan, Bingyi Shi, Hongshan Wei, Guosheng Du, Shujing Song. Comparison of hepatitis B X gene mutation between patients with hepatocellular carcinoma and patients with chronic hepatitis B. Virus Genes 2011; 42(2): 162 doi: 10.1007/s11262-010-0557-5
|
183 |
Chen-Shiou Wu, Yi-Chung Chien, Chia‐Jui Yen, Jia-Yan Wu, Li-Yuan Bai, Yung-Luen Yu. EZH2-mediated epigenetic silencing of tumor-suppressive let-7c/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasis. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-03002-9
|
184 |
Ali A. Rabaan, Kizito Eneye Bello, Ahmad Adebayo Irekeola, Nawal A. Al Kaabi, Muhammad A. Halwani, Amjad A. Yousuf, Amer Alshengeti, Amal H. Alfaraj, Faryal Khamis, Maha F. Al-Subaie, Bashayer M. AlShehail, Souad A. Almuthree, Noha Y. Ibraheem, Mahassen H. Khalifa, Mubarak Alfaresi, Mona A. Al Fares, Mohammed Garout, Ahmed Alsayyah, Ahmad A. Alshehri, Ali S. Alqahtani, Mohammed Alissa. Prevalence of Hepatocellular Carcinoma in Hepatitis B Population within Southeast Asia: A Systematic Review and Meta-Analysis of 39,050 Participants. Pathogens 2023; 12(10): 1220 doi: 10.3390/pathogens12101220
|
185 |
Li-ping Liu, Hui-fang Liang, Xiao-ping Chen, Wan-guang Zhang, Sheng-li Yang, Tao Xu, Li Ren. The Role of NF-κB in Hepatitis B Virus X Protein-Mediated Upregulation of VEGF and MMPs. Cancer Investigation 2010; 28(5): 443 doi: 10.3109/07357900903405959
|
186 |
Yilin Li, Yishuang Sun, Fuyun Sun, Rong Hua, Chenlin Li, Lang Chen, Deyin Guo, Jingfang Mu. Mechanisms and Effects on HBV Replication of the Interaction between HBV Core Protein and Cellular Filamin B. Virologica Sinica 2018; 33(2): 162 doi: 10.1007/s12250-018-0023-4
|
187 |
|
188 |
Xiaochen Tian, Chao Zhao, Jun Ren, Zhang-Mei Ma, You-Hua Xie, Yu-Mei Wen. Gene-expression profiles of a hepatitis B small surface antigen-secreting cell line reveal upregulation of lymphoid enhancer-binding factor 1.
Journal of General Virology
2007; 88(11): 2966 doi: 10.1099/vir.0.83108-0
|
189 |
Shi-Qiang Shen, Kun Li, Neng Zhu, Akimasa Nakao. Expression and clinical significance of NET-1 and PCNA in hepatocellular carcinoma. Medical Oncology 2008; 25(3): 341 doi: 10.1007/s12032-008-9042-6
|
190 |
Xiaoping Wang, Yongxue Zhou, Lijun Sun, Wei Chen, Xu Li, Qiaoxia Wang, Huanping Lin. Complex Formation between Heat Shock Protein 72 and Hepatitis B Virus X Protein in Hepatocellular Carcinoma Tissues. Journal of Proteome Research 2008; 7(12): 5133 doi: 10.1021/pr800435g
|
191 |
J. Ferrís i Tortajada, J.A. Ortega García, J. Garcia i Castell, J.A. López Andreu, C. Ribes Koninckx, O. Berbel Tornero. Factores de riesgo para los tumores hepáticos malignos pediátricos. Anales de Pediatría 2008; 68(4): 377 doi: 10.1157/13117711
|
192 |
Zdenko Herceg, Anupam Paliwal. Epigenetic mechanisms in hepatocellular carcinoma: How environmental factors influence the epigenome. Mutation Research/Reviews in Mutation Research 2011; 727(3): 55 doi: 10.1016/j.mrrev.2011.04.001
|
193 |
Lei Wang, Min Cao, Qing Lu Wei, Zhong Hua Zhao, Qin Xiang, Hui Juan Wang, Hua Tang Zhang, Guo Qi Lai, Haitao Guo. A new model mimicking persistent HBV e antigen-negative infection using covalently closed circular DNA in immunocompetent mice. PLOS ONE 2017; 12(4): e0175992 doi: 10.1371/journal.pone.0175992
|